- Email: [email protected]
Working group on quantitative ultrasound techniques in osteoporosis
ASBMR-IBMS
Concurrent
Chairpersons:
3:00 pm 1041
3:15 pm 1042
3:30 pm 1043
3:45 pm 1044
4:00 pm 1045
4:lS pm 1046
4:30 pm 1047
4:45 pm 1048
pm
Elizabeth
DIAGNOSIS Shane
and Markus
1, 1998
WELCOME RECEPTION AND PLENARY POSTERS*
Oral Session 6
OSTEOPOROSIS:
3:00 pm - 500
Tuesday, December
Second Joint Meeting
I
200 pm - 7:00 pm
Seibel Room
Exhibit Hall A Authors
500 pm - 790 pm
302
* Plenary
Structural Features of the Radius in Girls with Forearm Fractures. D. Dertina*, D. Skaggs*, T. Roe, M. L. Lore*, V. Gilsanz. Childrens Hospital Los Angeles. Los Angeles. California.
Posters
may be found
throughout
pages
Present
S7-S32.
WORKING GROUP ON QUANTITATIVE ULTRASOUND TECHNIQUES IN OSTEOPOROSIS Second Annual Meeting
Short-term Increases in Formation Markers Predict Subsequent Spine Bone Mineral Density Gains in Women with Glucocorticoid-induced Osteoporosis Treated with Parathyroid Hormone. Nancy E. Lane, Dean K. Jenkins. Claude D. Amaud. University of California, San Francisco. CA, Metra Biosystems, Mountain View, CA.
7:00 pm - 9:00
pm
Room 307
The Working Group on Quantitative Ultrasound Techniques in Osteoporosis provides a forum for researchers and clinicians to discuss the current status of this technology. Both fundamental introductions and innovative concepts will be presented. Ample time for discussion will be provided for in-depth exchange between speakers and the audience. Participants will receive updated publication lists on QUS.
Corticosteroids Do Not Alter the Threshold for Vertebral Fractures. Peter L. Selby, John P. Halsey*, Keatley R. H. Adams*, Peter S. Klimiuk*, Susan M. Knight*, Badal Pal*, Ian M. Stewart*, David R. Swinson*. Bone Disease Research Centre. University of Manchester, Manchester, UK, Royal Lancater Infirmary, Lancaster, UK, Royal Bolton Hospital, Bolton. UK, Royal Oldham Hospital, Oldham, UK, Macclesfield District General Hospital, Macclesfield, UK, University Hospital of South Manchester, Manchester. UK, Victoria Hospital, Blackpool, UK, Wrightington Hospital. Wigan, UK.
790
pm
7:lS pm
Are All QUS Approaches the Same? Introduction to Similarities and Differences Thomas Fuerst, Ph.D., University of California. San Francisco, California, USA
7:40 pm
The Clinical Debate: Can QUS Be Used for Monitoring Treatment? Richard Eastell. M.D.. University of Sheffield, Sheffield, United Kingdom Ruben Giorgino, M.D., Ph.D., Procter & Gamble. Rome, Italy Didier Hans, Ph.D., University of California, San Francisco, California, USA Leonard Rosenthall, M.D., McGill University, Montreal, Canada
8:25 pm
Panel Discussion: Monitoring with QUS
8:40 pm
QUS Research Prize: Presentation of Award The best QUS project among all abstracts accepted for the official ASBMR-IBMS program will be selected and awarded (US) $1,000.
Ability of Bone Biochemical Markers To Predict 4-Year Changes in Bone Density in Postmenopausal Women. S. M. Ott, D. C. Bauer, A. Santora. D. E. Thompson. University of Washington, Seattle, WA, University of California, San Francisco, CA, Merck & Co, Inc, Rahway, NJ. Long-term Variability of Biochemical Markers of Bone Turnover in Postmenopausal Women. R. A. Hannon, A. Blumsohn*, J. V. Ellison*. N. F. Peel, R. Eastell. Bone Metabolism Group, Division of Clinical Sciences (NGHT), University of Sheffield, Sheffield, UK. Bone Mineral Density Cannot Be Predicted Accurately by Clinical and Biochemical Variables in Perimenopausal Women. P. Vestergaard, A. P. Hermann, J. Gram, L. B. Jensen, P. Eiken. B. Abrahamsen, C. Brot, N. Kolthoff, 0. H. Sorensen. Nielsen Beck, Nielsen S. Pars, P. Charles. L. Mosekilde Danish Osteoporosis Prevention Study.
Dinner
850
pm
“QUS Horizons Lecture”: Use of QUS for Bone Disorders Other Than Osteoporosis David R. Reid, M.D.. University of Aberdeen, Scotland
Organizers and Session Moderators: Claus-C. Cliier, Ph.D.. University of Kiel. Kiel, Germany Maty L. Bouxsein, Ph.D., Harvard Medical School, Boston, Massachusetts, USA Thomas Fuerst, Ph.D., University of California, San Francisco, California, USA
Combining Bone Density and Risk Factors for Hip Fracture in Selecting Patients for Osteoporosis Treatment. M. Shea. B. Love McClung, M. McClung. Oregon Osteoporosis Center, Portland, OR.
ASBMR
QUS Research Award Committee: Mar?, L. Bouxsein, Ph.D., Harvard Medical School, Boston. USA Dieter Felsenberg, M.D., Free Universizy of Berlin, Germany Claus-C. Gliiel; Ph.D., University of Kiel, Germany Didier Hans, Ph.D., University of California, San Francisco, USA Alan Tenenhouse, M.D.. McGill University. Montreal, Canada
Visual Vertebral Deformity Assessment by X-Ray Absorptiometry: A Highly Predictive Method To Rule Out Vertebral Fractures. J. A. Rea. M. Chen, J. Li, G. M. Blake, P. Steiger, H. K. Genant. I. Fogelman. Guy’s Hospital, London, UK. Hologic Inc, Waltham. MA, USA, Osteoporosis & Arthritis Research Group, University of California, San Francisco, USA.
s37
Concurrent
Chairpersons:
3:00 pm 1041
3:15 pm 1042
3:30 pm 1043
3:45 pm 1044
4:00 pm 1045
4:lS pm 1046
4:30 pm 1047
4:45 pm 1048
pm
Elizabeth
DIAGNOSIS Shane
and Markus
1, 1998
WELCOME RECEPTION AND PLENARY POSTERS*
Oral Session 6
OSTEOPOROSIS:
3:00 pm - 500
Tuesday, December
Second Joint Meeting
I
200 pm - 7:00 pm
Seibel Room
Exhibit Hall A Authors
500 pm - 790 pm
302
* Plenary
Structural Features of the Radius in Girls with Forearm Fractures. D. Dertina*, D. Skaggs*, T. Roe, M. L. Lore*, V. Gilsanz. Childrens Hospital Los Angeles. Los Angeles. California.
Posters
may be found
throughout
pages
Present
S7-S32.
WORKING GROUP ON QUANTITATIVE ULTRASOUND TECHNIQUES IN OSTEOPOROSIS Second Annual Meeting
Short-term Increases in Formation Markers Predict Subsequent Spine Bone Mineral Density Gains in Women with Glucocorticoid-induced Osteoporosis Treated with Parathyroid Hormone. Nancy E. Lane, Dean K. Jenkins. Claude D. Amaud. University of California, San Francisco. CA, Metra Biosystems, Mountain View, CA.
7:00 pm - 9:00
pm
Room 307
The Working Group on Quantitative Ultrasound Techniques in Osteoporosis provides a forum for researchers and clinicians to discuss the current status of this technology. Both fundamental introductions and innovative concepts will be presented. Ample time for discussion will be provided for in-depth exchange between speakers and the audience. Participants will receive updated publication lists on QUS.
Corticosteroids Do Not Alter the Threshold for Vertebral Fractures. Peter L. Selby, John P. Halsey*, Keatley R. H. Adams*, Peter S. Klimiuk*, Susan M. Knight*, Badal Pal*, Ian M. Stewart*, David R. Swinson*. Bone Disease Research Centre. University of Manchester, Manchester, UK, Royal Lancater Infirmary, Lancaster, UK, Royal Bolton Hospital, Bolton. UK, Royal Oldham Hospital, Oldham, UK, Macclesfield District General Hospital, Macclesfield, UK, University Hospital of South Manchester, Manchester. UK, Victoria Hospital, Blackpool, UK, Wrightington Hospital. Wigan, UK.
790
pm
7:lS pm
Are All QUS Approaches the Same? Introduction to Similarities and Differences Thomas Fuerst, Ph.D., University of California. San Francisco, California, USA
7:40 pm
The Clinical Debate: Can QUS Be Used for Monitoring Treatment? Richard Eastell. M.D.. University of Sheffield, Sheffield, United Kingdom Ruben Giorgino, M.D., Ph.D., Procter & Gamble. Rome, Italy Didier Hans, Ph.D., University of California, San Francisco, California, USA Leonard Rosenthall, M.D., McGill University, Montreal, Canada
8:25 pm
Panel Discussion: Monitoring with QUS
8:40 pm
QUS Research Prize: Presentation of Award The best QUS project among all abstracts accepted for the official ASBMR-IBMS program will be selected and awarded (US) $1,000.
Ability of Bone Biochemical Markers To Predict 4-Year Changes in Bone Density in Postmenopausal Women. S. M. Ott, D. C. Bauer, A. Santora. D. E. Thompson. University of Washington, Seattle, WA, University of California, San Francisco, CA, Merck & Co, Inc, Rahway, NJ. Long-term Variability of Biochemical Markers of Bone Turnover in Postmenopausal Women. R. A. Hannon, A. Blumsohn*, J. V. Ellison*. N. F. Peel, R. Eastell. Bone Metabolism Group, Division of Clinical Sciences (NGHT), University of Sheffield, Sheffield, UK. Bone Mineral Density Cannot Be Predicted Accurately by Clinical and Biochemical Variables in Perimenopausal Women. P. Vestergaard, A. P. Hermann, J. Gram, L. B. Jensen, P. Eiken. B. Abrahamsen, C. Brot, N. Kolthoff, 0. H. Sorensen. Nielsen Beck, Nielsen S. Pars, P. Charles. L. Mosekilde Danish Osteoporosis Prevention Study.
Dinner
850
pm
“QUS Horizons Lecture”: Use of QUS for Bone Disorders Other Than Osteoporosis David R. Reid, M.D.. University of Aberdeen, Scotland
Organizers and Session Moderators: Claus-C. Cliier, Ph.D.. University of Kiel. Kiel, Germany Maty L. Bouxsein, Ph.D., Harvard Medical School, Boston, Massachusetts, USA Thomas Fuerst, Ph.D., University of California, San Francisco, California, USA
Combining Bone Density and Risk Factors for Hip Fracture in Selecting Patients for Osteoporosis Treatment. M. Shea. B. Love McClung, M. McClung. Oregon Osteoporosis Center, Portland, OR.
ASBMR
QUS Research Award Committee: Mar?, L. Bouxsein, Ph.D., Harvard Medical School, Boston. USA Dieter Felsenberg, M.D., Free Universizy of Berlin, Germany Claus-C. Gliiel; Ph.D., University of Kiel, Germany Didier Hans, Ph.D., University of California, San Francisco, USA Alan Tenenhouse, M.D.. McGill University. Montreal, Canada
Visual Vertebral Deformity Assessment by X-Ray Absorptiometry: A Highly Predictive Method To Rule Out Vertebral Fractures. J. A. Rea. M. Chen, J. Li, G. M. Blake, P. Steiger, H. K. Genant. I. Fogelman. Guy’s Hospital, London, UK. Hologic Inc, Waltham. MA, USA, Osteoporosis & Arthritis Research Group, University of California, San Francisco, USA.
s37